Amplified RNA Degradation in T7-amplification Methods Results in Biased Microarray Hybridizations

Overview

Journal BMC Genomics

Publisher Biomed Central

Specialty Genetics

Date 2003 Nov 11

PMID 14606961

Citations 19

Authors

Andrej-Nikolai Spiess

Nadine Mueller

Richard Ivell

Affiliations

Soon will be listed here.

Abstract

Background: The amplification of RNA with the T7-System is a widely used technique for obtaining increased amounts of RNA starting from limited material. The amplified RNA (aRNA) can subsequently be used for microarray hybridizations, warranting sufficient signal for image analysis. We describe here an amplification-time dependent degradation of aRNA in prolonged standard T7 amplification protocols, that results in lower average size aRNA and decreased yields.

Results: A time-dependent degradation of amplified RNA (aRNA) could be observed when using the classical "Eberwine" T7-Amplification method. When the amplification was conducted for more than 4 hours, the resulting aRNA showed a significantly smaller size distribution on gel electrophoresis and a concomitant reduction of aRNA yield. The degradation of aRNA could be correlated to the presence of the T7 RNA Polymerase in the amplification cocktail. The aRNA degradation resulted in a strong bias in microarray hybridizations with a high coefficient of variation and a significant reduction of signals of certain transcripts, that seem to be susceptible to this RNA degrading activity. The time-dependent degradation of these transcripts was verified by a real-time PCR approach.

Conclusions: It is important to perform amplifications not longer than 4 hours as there is a characteristic 'quality vs. yield' situation for longer amplification times. When conducting microarray hybridizations it is important not to compare results obtained with aRNA from different amplification times.

Citing Articles

Robust transcriptional signatures for low-input RNA samples based on relative expression orderings.

Liu H, Li Y, He J, Guan Q, Chen R, Yan H BMC Genomics. 2017; 18(1):913.

PMID: 29179677 PMC: 5704640. DOI: 10.1186/s12864-017-4280-7.

Genome-Wide Analysis of Periodontal and Peri-Implant Cells and Tissues.

Kebschull M, Hulsmann C, Hoffmann P, Papapanou P Methods Mol Biol. 2016; 1537:307-326.

PMID: 27924602 PMC: 6554644. DOI: 10.1007/978-1-4939-6685-1_18.

Comparative analysis of response to selection with three insecticides in the dengue mosquito Aedes aegypti using mRNA sequencing.

David J, Faucon F, Chandor-Proust A, Poupardin R, Riaz M, Bonin A BMC Genomics. 2014; 15:174.

PMID: 24593293 PMC: 4029067. DOI: 10.1186/1471-2164-15-174.

Adjustment method for microarray data generated using two-cycle RNA labeling protocol.

Wang F, Chen R, Ji D, Bai S, Qian M, Deng M BMC Genomics. 2013; 14:31.

PMID: 23324182 PMC: 3658951. DOI: 10.1186/1471-2164-14-31.

Estimating RNA-quality using GeneChip microarrays.

Fasold M, Binder H BMC Genomics. 2012; 13:186.

PMID: 22583818 PMC: 3519671. DOI: 10.1186/1471-2164-13-186.

References

Bowtell D . Options available--from start to finish--for obtaining expression data by microarray. Nat Genet. 1999; 21(1 Suppl):25-32. DOI: 10.1038/4455. View

Lockhart D, Winzeler E . Genomics, gene expression and DNA arrays. Nature. 2000; 405(6788):827-36. DOI: 10.1038/35015701. View

Baugh L, Hill A, Brown E, Hunter C . Quantitative analysis of mRNA amplification by in vitro transcription. Nucleic Acids Res. 2001; 29(5):E29. PMC: 29742. DOI: 10.1093/nar/29.5.e29. View

Schena M, Shalon D, Davis R, Brown P . Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 1995; 270(5235):467-70. DOI: 10.1126/science.270.5235.467. View

Van Gelder R, von Zastrow M, Yool A, Dement W, Barchas J, Eberwine J . Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc Natl Acad Sci U S A. 1990; 87(5):1663-7. PMC: 53542. DOI: 10.1073/pnas.87.5.1663. View

Zhao H, Hastie T, Whitfield M, Borresen-Dale A, Jeffrey S . Optimization and evaluation of T7 based RNA linear amplification protocols for cDNA microarray analysis. BMC Genomics. 2002; 3(1):31. PMC: 137577. DOI: 10.1186/1471-2164-3-31. View

Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C . Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet. 2001; 29(4):365-71. DOI: 10.1038/ng1201-365. View

Arnold S, Siemann M, Scharnweber K, Werner M, Baumann S, Reuss M . Kinetic modeling and simulation of in vitro transcription by phage T7 RNA polymerase. Biotechnol Bioeng. 2001; 72(5):548-61. View

Binder R, Horowitz J, Basilion J, Koeller D, Klausner R, Harford J . Evidence that the pathway of transferrin receptor mRNA degradation involves an endonucleolytic cleavage within the 3' UTR and does not involve poly(A) tail shortening. EMBO J. 1994; 13(8):1969-80. PMC: 395039. DOI: 10.1002/j.1460-2075.1994.tb06466.x. View

10.

Nygaard V, Loland A, Holden M, Langaas M, Rue H, Liu F . Effects of mRNA amplification on gene expression ratios in cDNA experiments estimated by analysis of variance. BMC Genomics. 2003; 4(1):11. PMC: 153514. DOI: 10.1186/1471-2164-4-11. View

11.

Lukyanov K, Diatchenko L, Chenchik A, Nanisetti A, Siebert P, Usman N . Construction of cDNA libraries from small amounts of total RNA using the suppression PCR effect. Biochem Biophys Res Commun. 1997; 230(2):285-8. DOI: 10.1006/bbrc.1996.5948. View

12.

Pfaffl M . A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29(9):e45. PMC: 55695. DOI: 10.1093/nar/29.9.e45. View

13.

Huels C, Muellner S, Meyer H, Cahill D . The impact of protein biochips and microarrays on the drug development process. Drug Discov Today. 2003; 7(18 Suppl):S119-24. DOI: 10.1016/s1359-6446(02)02389-9. View

14.

Yang I, Chen E, Hasseman J, Liang W, Frank B, Wang S . Within the fold: assessing differential expression measures and reproducibility in microarray assays. Genome Biol. 2002; 3(11):research0062. PMC: 133446. DOI: 10.1186/gb-2002-3-11-research0062. View

15.

Bertucci F, Viens P, Hingamp P, Nasser V, Houlgatte R, Birnbaum D . Breast cancer revisited using DNA array-based gene expression profiling. Int J Cancer. 2002; 103(5):565-71. DOI: 10.1002/ijc.10867. View

16.

Lockhart D, Dong H, Byrne M, Follettie M, Gallo M, Chee M . Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol. 1996; 14(13):1675-80. DOI: 10.1038/nbt1296-1675. View

17.

Puskas L, Zvara A, Hackler Jr L, Van Hummelen P . RNA amplification results in reproducible microarray data with slight ratio bias. Biotechniques. 2002; 32(6):1330-4, 1336, 1338, 1340. DOI: 10.2144/02326mt04. View

18.

Mignone F, Gissi C, Liuni S, Pesole G . Untranslated regions of mRNAs. Genome Biol. 2002; 3(3):REVIEWS0004. PMC: 139023. DOI: 10.1186/gb-2002-3-3-reviews0004. View

19.

Cunningham P, OFENGAND J . Use of inorganic pyrophosphatase to improve the yield of in vitro transcription reactions catalyzed by T7 RNA polymerase. Biotechniques. 1990; 9(6):713-4. View

20.

Mutch D, Berger A, Mansourian R, Rytz A, Roberts M . The limit fold change model: a practical approach for selecting differentially expressed genes from microarray data. BMC Bioinformatics. 2002; 3:17. PMC: 117238. DOI: 10.1186/1471-2105-3-17. View